Breaking News Instant updates and real-time market news.

XLV

Health Care Select Sector SPDR

$88.46 /

-0.18 (-0.20%)

08:18
05/20/19
05/20
08:18
05/20/19
08:18

Health Care Select Sector SPDR: Pivot points

The following are the pivot points for the Health Care Select Sector SPDR (XLV). Pivot High: $89.41, Pivot Low: $88.17. These were calculated using the DeMark method. It is generally believed to be bullish when price breaks out above the pivot high or bearish when price breaks down below the pivot low.

TODAY'S FREE FLY STORIES

Earnings
Turning Point Brands reports Q4 EPS 41c, consensus 46c » 07:39
02/26/20
02/26
07:39
02/26/20
07:39
TPB

Turning Point Brands

$22.67 /

-1.13 (-4.75%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Boise Cascade upgraded to Buy from Neutral at DA Davidson » 07:39
02/26/20
02/26
07:39
02/26/20
07:39
BCC

Boise Cascade

$36.82 /

-3.39 (-8.43%)

DA Davidson analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
BioXcel Therapeutics price target raised to $95 from $30 at H.C. Wainwright » 07:38
02/26/20
02/26
07:38
02/26/20
07:38
BTAI

BioXcel Therapeutics

$29.57 /

-2.63 (-8.17%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
RTW Retailwinds announces multi-year partnership with Salesforce » 07:37
02/26/20
02/26
07:37
02/26/20
07:37
RTW

RTW Retailwinds

$0.34 /

-0.0258 (-7.01%)

, CRM

Salesforce

$181.65 /

-4.26 (-2.29%)

RTW Retailwinds (RTW)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Insulet weakness a buying opportunity, says Cowen » 07:37
02/26/20
02/26
07:37
02/26/20
07:37
PODD

Insulet

$197.03 /

-10.46 (-5.04%)

Cowen analyst Ryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Cars.com reports Q4 adjusted EPS 63c, consensus 37c » 07:36
02/26/20
02/26
07:36
02/26/20
07:36
CARS

Cars.com

$10.57 /

-1.48 (-12.28%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Actinium Pharmaceuticals expands CD33 program » 07:36
02/26/20
02/26
07:36
02/26/20
07:36
ATNM

Actinium Pharmaceuticals

$0.23 /

-0.0162 (-6.61%)

Actinium Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Kiniksa expects cash reserves to fund operating plan into 2H21 » 07:36
02/26/20
02/26
07:36
02/26/20
07:36
KNSA

Kiniksa

$17.85 /

-0.73 (-3.93%)

Kiniksa expects that its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Revance price target raised to $28 from $23 at H.C. Wainwright » 07:36
02/26/20
02/26
07:36
02/26/20
07:36
RVNC

Revance

$24.77 /

-2.155 (-8.01%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Axcella completes subject enrollment in AXA1665-002 Study » 07:35
02/26/20
02/26
07:35
02/26/20
07:35
AXLA

Axcella

$4.51 /

-0.34 (-7.01%)

Axcella announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Kiniksa expects topline data from Phase 1 trial of KPL-404 in 2H20 » 07:35
02/26/20
02/26
07:35
02/26/20
07:35
KNSA

Kiniksa

$17.85 /

-0.73 (-3.93%)

KPL-404: Kiniksa is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Clean Harbors reports Q4 adj. EPS 42c, consensus 46c » 07:35
02/26/20
02/26
07:35
02/26/20
07:35
CLH

Clean Harbors

$81.66 /

-3.07 (-3.62%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
GW Pharmaceuticals price target lowered to $173 from $203 at Oppenheimer » 07:35
02/26/20
02/26
07:35
02/26/20
07:35
GWPH

GW Pharmaceuticals

$116.77 /

-4.1 (-3.39%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Kiniksa expects data from Phase 2a trial of KPL-716 in April 2020 » 07:35
02/26/20
02/26
07:35
02/26/20
07:35
KNSA

Kiniksa

$17.85 /

-0.73 (-3.93%)

KPL-716: Kiniksa is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
SmileDirectClub price target lowered to $12 from $17 at Stifel » 07:34
02/26/20
02/26
07:34
02/26/20
07:34
SDC

SmileDirectClub

$11.33 /

-0.51 (-4.31%)

Stifel analyst Jonathan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Sinclair Broadcast sees Q1 revenue $1.647B-$1.675B, consensus $1.66B  07:34
02/26/20
02/26
07:34
02/26/20
07:34
SBGI

Sinclair Broadcast

$27.58 /

-0.64 (-2.27%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Kiniksa expects topline data from Phase 2 PoC trial of mavrilimumab in 2H20 » 07:34
02/26/20
02/26
07:34
02/26/20
07:34
KNSA

Kiniksa

$17.85 /

-0.73 (-3.93%)

, GILD

Gilead

$70.13 /

-2.82 (-3.87%)

Mavrilimumab: Kiniksa…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Ameren sees FY20 EPS $3.40-$3.60, consensus $3.46 » 07:34
02/26/20
02/26
07:34
02/26/20
07:34
AEE

Ameren

$83.61 /

-1.2 (-1.41%)

Affirms its 2018-2023…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
LTC Properties upgraded to Buy from Hold at Berenberg » 07:33
02/26/20
02/26
07:33
02/26/20
07:33
LTC

LTC Properties

$49.39 /

-0.64 (-1.28%)

Berenberg analyst Connor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Sinclair Broadcast reports Q4 EPS 47c, may not compare to consensus $1.03 » 07:33
02/26/20
02/26
07:33
02/26/20
07:33
SBGI

Sinclair Broadcast

$27.58 /

-0.64 (-2.27%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Kiniksa expects topline data from RHAPSODY trial in 2H20 » 07:32
02/26/20
02/26
07:32
02/26/20
07:32
KNSA

Kiniksa

$17.85 /

-0.73 (-3.93%)

Rilonacept: Kiniksa is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
CoStar Group price target raised to $790 from $650 at SunTrust » 07:32
02/26/20
02/26
07:32
02/26/20
07:32
CSGP

CoStar Group

$696.60 /

-10.39 (-1.47%)

SunTrust analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Planet Fitness price target raised to $77 from $69 at Wedbush » 07:32
02/26/20
02/26
07:32
02/26/20
07:32
PLNT

Planet Fitness

$81.51 /

-2.87 (-3.40%)

Wedbush analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Kiniksa reports Q4 EPS (58c), consensus (62c) » 07:31
02/26/20
02/26
07:31
02/26/20
07:31
KNSA

Kiniksa

$17.85 /

-0.73 (-3.93%)

"We have the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Ameren reports Q4 EPS 38c, consensus 31c » 07:31
02/26/20
02/26
07:31
02/26/20
07:31
AEE

Ameren

$83.61 /

-1.2 (-1.41%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.